Hematology· Topic 6.1 Hypoproliferative anemia and disorders of heme synthesis· 6.1.10

Porphyria

The porphyrias are inherited or acquired defects of heme biosynthesis enzymes that cause toxic accumulation of porphyrin precursors, splitting into acute hepatic porphyria (neurovisceral attacks with no photosensitivity, confirmed by elevated urinary porphobilinogen) and porphyria cutanea tarda (blistering photosensitivity from elevated urinary uroporphyrins). Acute attacks are treated with IV hemin and glucose loading, while porphyria cutanea tarda responds to phlebotomy or low-dose hydroxychloroquine.

6 min read3 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: the porphyrias are hereditary or acquired conditions caused by defective activity of a specific heme-biosynthesis enzyme, causing accumulation of the precursor upstream of the block.

  • Epidemiology

    AIP: autosomal dominant with low penetrance, so most gene carriers stay clinically silent for life; expression requires a trigger, and symptomatic attacks are more common in women, typically after puberty.

  • Risk factors

    Cytochrome P450-inducing drugs precipitate acute attacks: sulfonamides, barbiturates, other CYP450 inducers, antipsychotics, and alcohol upregulate ALA synthase and provoke an AIP attack in a susceptible carrier.

  • Pathophysiology

    Heme synthesis is blocked at a specific enzyme step: each porphyria corresponds to deficient activity of one pathway enzyme, so the precursor immediately upstream of the block accumulates.

  • Clinical features

    AIP acute attack, the 5 P's: painful abdomen (colicky, moderate to severe, lasting hours to days, no peritoneal signs), port wine-colored urine (darkens on standing), polyneuropathy (motor greater…

  • Differential diagnosis

    Acute abdomen (appendicitis, cholecystitis, bowel obstruction): true surgical disease shows peritoneal signs, fever, or imaging of an obstructing/inflamed viscus, all absent in a porphyric attack…

  • Diagnosis

    Acute hepatic porphyria is confirmed by a markedly elevated urinary PBG, with ALA also elevated, measured during the symptomatic attack because levels normalize between episodes; a normal PBG during…

  • Management

    Acute attack, stabilize and remove precipitants first: discontinue all CYP450-inducing and other porphyrinogenic drugs and treat any underlying infection.

  • Complications

    Respiratory failure from ascending motor neuropathy: severe AIP attacks can progress to bulbar and diaphragmatic weakness requiring mechanical ventilation, the most dangerous acute complication.

  • Prognosis

    AIP attacks resolve with prompt treatment: most improve within days of hemin and glucose therapy and precipitant removal, though motor neuropathy can take months to fully recover.

  • Prevention

    Avoid known precipitants in AIP carriers: strict avoidance of CYP450-inducing drugs (barbiturates, many anticonvulsants, sulfonamide antibiotics, certain antipsychotics) and alcohol, plus adequate…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.